Connexion Media enters into agreement with Chinese auto hardware vendor


Published 22-FEB-2017 13:30 P.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Only 24 hours after being awarded Gold Partner status by Microsoft, developer and distributor of smart car software apps and services, Connexion Media (ASX: CXZ) has entered into a Memorandum of Understanding with Chinese auto hardware vendor, Tass Internet of Vehicles Co. Limited (TassIOV), a group which currently supplies embedded hardware devices to two Chinese based automakers, and has commercial relationships with an additional five China-based automakers.

While yesterday’s news triggered a 20% spike in the company’s share price, this is a significant development for the company and could be a catalyst for further upside.

Although, it should be noted that share trading patterns should not be used as the basis for an investment as they may not be replicated. Those considering this stock should seek independent financial advice.

The agreement will include reciprocal distribution with TassIOV to co-sell CXZ telematics services to China-based automakers and CXZ to co-sell TassIOV’s hardware devices into the European and US automaker markets where it benefits from established relationships with automakers and aftermarket manufacturers based in those regions.

Given the size of the Chinese automotive market where annual new vehicle sales are expected to exceed 22 million units by 2020, this should be viewed as a substantial commercial opportunity for CXZ.

In tandem with growth in vehicle sales off an already strong base in China is the accelerating inclusion of software apps and services in order to meet demand for Internet connected vehicles and mobile devices.

The other important factor in this agreement is that it provides exposure to the aftermarket hardware devices sector, an industry which often offers superior margins than providing OEM products to motor vehicle manufacturers.

As a backdrop, TassIOV was established in 2015 as a supplier of embedded and aftermarket hardware devices and OBD-11 devices for Chinese manufactured vehicles.

The two China-based automakers it currently supplies include TassIOV’s hardware devices as standard equipment in their motor vehicles. The company has the capacity to manufacture 1.5 million devices per annum for the Chinese market.

Under the terms of the agreement both parties will collaborate to produce integrated hardware offerings that embed CXZ’s telematics software into TassIOV’s hardware products for distribution across the Chinese market.

The agreement will also see CXZ work with TassIOV to develop new SaaS solutions for the Chinese market with CXZ capturing all of the Chinese in-vehicle data generated by its partner’s devices.

Despite being approached by several Chinese parties wanting to collaborate with CXZ over the last 12 months, management has taken a measured approach in terms of committing to a collaboration agreement.

Chief Executive of CXZ, George Parthimos, said that a partnership with TassIOV was attractive because of the group’s substantive existing customer networks across China, and as such he believes this is likely to represent an opportunity for the company to be an early mover in the Chinese connected car market.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free